---
title: "信达生物宣布 Jaypirca 已获得中国国家药品监督管理局的批准"
description: "信达生物表示，Jaypirca 已获得中国国家药品监督管理局（NMPA）的批准"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/277222255.md"
published_at: "2026-02-27T15:31:11.000Z"
---

# 信达生物宣布 Jaypirca 已获得中国国家药品监督管理局的批准

> 信达生物表示，Jaypirca 已获得中国国家药品监督管理局（NMPA）的批准

### Related Stocks

- [589720.CN - 国泰上证科创板创新药ETF](https://longbridge.com/zh-CN/quote/589720.CN.md)
- [512290.CN - 国泰中证生物医药ETF](https://longbridge.com/zh-CN/quote/512290.CN.md)
- [516500.CN - 华夏中证生物科技主题ETF](https://longbridge.com/zh-CN/quote/516500.CN.md)
- [159615.CN - 南方恒生生物科技ETF(QDII)](https://longbridge.com/zh-CN/quote/159615.CN.md)
- [513120.CN - 广发中证香港创新药(QDII-ETF)](https://longbridge.com/zh-CN/quote/513120.CN.md)
- [159859.CN - 天弘国证生物医药ETF](https://longbridge.com/zh-CN/quote/159859.CN.md)
- [560600.CN - 方正富邦中证医药及医疗器械创新ETF](https://longbridge.com/zh-CN/quote/560600.CN.md)
- [516820.CN - 平安中证医疗创新ETF](https://longbridge.com/zh-CN/quote/516820.CN.md)
- [588860.CN - 科创医药ETF工银](https://longbridge.com/zh-CN/quote/588860.CN.md)
- [159506.CN - 富国恒生港股通创新药及医疗保健ETF](https://longbridge.com/zh-CN/quote/159506.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CStone Wins Second UK Approval for Lung Cancer Drug Sugemalimab | CStone Pharmaceuticals has received UK approval for its lung cancer drug, sugemalimab, as a monotherapy for adult patien | [Link](https://longbridge.com/zh-CN/news/276549711.md) |
| Shanghai Pharmaceuticals Obtains Singapore Marketing Approval for Anticoagulant Drug | Shanghai Pharmaceuticals Obtains Singapore Marketing Approval for Anticoagulant Drug | [Link](https://longbridge.com/zh-CN/news/276822785.md) |
| Hangzhou Jiuyuan’s Semaglutide Biosimilar Jikeqin Advances Toward China Market Approval | Hangzhou Jiuyuan Gene Engineering Co Ltd has developed Jikeqin, a biosimilar of semaglutide for weight management. The d | [Link](https://longbridge.com/zh-CN/news/276936312.md) |
| Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | [Link](https://longbridge.com/zh-CN/news/276886600.md) |
| China Medical System Gets China Acceptance for Atopic Dermatitis Drug | China Medical System Gets China Acceptance for Atopic Dermatitis Drug | [Link](https://longbridge.com/zh-CN/news/276718382.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。